Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | GAA | P10253 | 3/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23775709 | 0.92 | GAA (0.73) | MEN1KMT2AGAAHPGDL3MBTL1 | |
| SCHEMBL7113886 | 0.92 | GAA (0.73) | MEN1KMT2AGAAHPGDL3MBTL1 | |
| SCHEMBL20367165 | 0.87 | MEN1 (0.56) | MEN1KMT2AGAAHPGDL3MBTL1 | |
| SCHEMBL9479370 | 0.84 | KMT2A (1.00) | MEN1KMT2AGAAHPGDALDH1A1 | |
| SCHEMBL92717 | 0.84 | KMT2A (1.00) | MEN1KMT2AGAAHPGDALDH1A1 | |
| SCHEMBL1952693 | 0.84 | KMT2A (1.00) | MEN1KMT2AGAAHPGDALDH1A1 | |
| SCHEMBL891138 | 0.83 | GAA (0.80) | MEN1KMT2AGAAHPGDL3MBTL1 | |
| (Phenylsulfonyl)Benzene SCHEMBL28101401 | 0.83 | HTR6 (0.70) | MEN1KMT2AGAAHPGDL3MBTL1 | |
| SCHEMBL172875 | 0.83 | HPGD (1.00) | MEN1KMT2AGAAHPGDL3MBTL1 | |
| SCHEMBL9461706 | 0.83 | HPGD (1.00) | MEN1KMT2AGAAHPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115678643-B | Hydraulic fluid | 雅富顿化学公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230272563-A1 | TEXTILES AND ARTICLES, AND PROCESSES FOR MAKING THE SAME | NIKE, INC. | 2023-08-31 | — | — | US | disclosed |
| US-20230140606-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | ENALARE THERAPEUTICS INC. | 2023-05-04 | — | — | US | disclosed |
| WO-2021161838-A1 | DIARYLAMINE COMPOUND, SURFACE-TREATED FILLER, AND POLYMER COMPOSITION | 日本ゼオン株式会社 | 2021-08-19 | — | — | WO | disclosed |
| CN-104122719-A | Method of manufacturing liquid crystal display device | SAMSUNG DISPLAY CO LTD | 2014-10-29 | — | — | CN | disclosed |
| US-5672704-A | ULTRAVIOLET RADIATION STABILIZERS | CIBA-GEIGY CORPORATION | 1997-09-30 | — | — | US | disclosed |
| US-5668206-A | OIL AND POLYMER ADDITIVES | CIBA-GEIGY CORPORATION (US) | 1997-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230140606-A1 | METHODS OF TREATING RESPIRATORY DEPRESSION MODULATED BY A NON-OPIOID AGENT | OPRK1, OPRM1, OPRD1 | MEN1 4868/4885KMT2A 1896/4885GAA 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.